Executive Appointments and Compensation - Jill Putman appointed as Interim Chief Financial Officer effective January 3, 2025, replacing Tania Secor[5] - Jill Putman to receive monthly cash compensation of $83,333 and a one-time equity award of $1,200,000 in RSUs[8] - RSUs vest over 1 year: 16.67% monthly for the first 3 months, then 5.56% monthly for the remaining 9 months[8] Board and Committee Changes - Robert Lord appointed as Chair of the Audit Committee, replacing Jill Putman[6] - Jill Putman has served on the Board since January 2021 and holds board positions at Arctic Wolf Networks and Avalara[7] Legal and Contractual Agreements - The Consulting Agreement includes confidentiality and assignment of invention provisions[8] - The Consulting Agreement is filed as Exhibit 10.1[10] Corporate Governance and Disclosures - No family relationships or reportable transactions exist between Jill Putman and the company's directors or executives[9] - The company confirms no arrangements or understandings influenced Jill Putman's appointment[9] - The press release regarding Jill Putman's appointment is attached as Exhibit 99.1[11]

Financial Results - Integral Ad Science Holding Corp. is set to release its fourth-quarter financial results on February 28, 2025, before the market opens [1] - Analysts anticipate quarterly earnings of 25 cents per share, an increase from 16 cents per share in the same period last year [1] - Projected quarterly revenue is $148.83 million, compared to $134.29 million a year earlier [1] Management Changes - On January 3, 2025, Integral Ad Science announced the departure of Tania Secor as Chief Financial Officer and appointed Jill Putman as Interim CFO [2] - Following the announcement, Integral Ad Science shares fell by 2% to close at $9.65 [2] Analyst Ratings - Scotiabank analyst Nat Schindler initiated coverage with a Sector Perform rating and a price target of $10 [4] - Benchmark analyst Mark Zgutowicz reiterated a Hold rating [4] - Oppenheimer analyst Jason Helfstein maintained an Outperform rating but reduced the price target from $20 to $18 [4] - Truist Securities analyst Youssef Squali maintained a Buy rating and cut the price target from $18 to $16 [4] - Barclays analyst Raimo Lenschow maintained an Equal-Weight rating and raised the price target from $12 to $13 [4]

Group 1 - A class action has been filed on behalf of shareholders who purchased Integral Ad Science Holding Corp. (NASDAQ: IAS) common stock between March 2, 2023, and February 27, 2024 [1] - The allegations include that IAS misled investors about its business prospects, specifically regarding competitive pricing pressures and the inability to sustain pricing [2] - On February 27, 2024, IAS announced disappointing financial results for Q4 and the full year ended December 31, 2023, leading to a significant stock price decline of approximately 41% on February 28, 2024 [2] Group 2 - Shareholders interested in serving as lead plaintiffs must file papers with the court by March 31, 2025 [3] - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [3] - Robbins LLP has been dedicated to helping shareholders recover losses and improve corporate governance since 2002 [4]

Group 1 - Integral Ad Science (IAS) is expected to report quarterly earnings of $0.12 per share, reflecting a year-over-year increase of 100% [1] - Revenues are projected to be $149.13 million, which represents an 11% increase from the same quarter last year [1] - There has been a downward revision of 12.5% in the consensus EPS estimate over the past 30 days, indicating a reappraisal by analysts [1] Group 2 - Analysts estimate 'Revenue- Optimization revenue' to be $69.20 million, showing a year-over-year change of +8.8% [4] - 'Revenue- Publisher revenue' is expected to reach $20.52 million, indicating a change of +13.4% year over year [4] - 'Revenue- Measurement revenue' is projected to be $59.05 million, reflecting a year-over-year change of +12.3% [4] Group 3 - IAS shares have returned +1% over the past month, contrasting with the Zacks S&P 500 composite's -1.8% change [5] - IAS holds a Zacks Rank 3 (Hold), suggesting it is expected to perform in line with the overall market in the near future [5]

Core Viewpoint - A class action securities lawsuit has been filed against Integral Ad Science Holding Corp. for alleged securities fraud affecting investors between March 2, 2023, and February 27, 2024 [1] Group 1: Allegations of Fraud - The lawsuit claims that Integral Ad Science concealed a new trend of increased competitive pricing pressures, leading to price cuts due to weakening demand and slowing revenue growth [2] - It is alleged that the company's pricing function was no longer favorable, impacting its ability to sustain pricing and drive price increases [2] - The complaint states that pricing had become a key differentiator necessary for closing major renewals and new deals, which was not disclosed [2] - The risks associated with competition leading to increased pricing pressure were realized, contradicting the company's public statements [2] Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until March 31, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating no financial obligation to participate [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the U.S. for seven consecutive years [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Integral Ad Science Holding Corp. (NASDAQ: IAS) during the specified Class Period of the upcoming lead plaintiff deadline on March 31, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought IAS common stock between March 2, 2023, and February 27, 2024, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [2][5]. - The deadline to move the Court to serve as lead plaintiff is March 31, 2025, with the lead plaintiff acting on behalf of other class members [2]. Group 2: Case Allegations - The lawsuit alleges that IAS failed to disclose significant competitive pricing pressures, which forced the company to cut prices due to weakening demand and slowing revenue growth [4]. - It is claimed that IAS's pricing function was no longer favorable, and the company could not sustain its pricing or drive price increases [4]. - The lawsuit asserts that IAS's public statements were materially false and misleading, leading to investor damages when the true situation was revealed [4]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [3]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [3]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [3].

Core Viewpoint - A securities class action lawsuit has been filed against Integral Ad Science Holding Corp. (IAS) for allegedly making materially false and misleading statements regarding its business operations and financial prospects during the class period from March 2, 2023, to February 27, 2024 [1]. Group 1: Allegations Against IAS - The lawsuit claims that IAS faced increased competitive pricing pressures, leading to price cuts due to weakening demand and slowing revenue growth [2]. - It is alleged that IAS's pricing function was no longer favorable, and the company could not sustain its pricing or drive price increases [2]. - The complaint states that pricing had become a key differentiator between IAS and its competitors, and favorable pricing was necessary to secure major renewals and new deals [2]. - The risk of increased pricing pressure from competition had materialized, contradicting IAS's previous statements about its business and operations [2]. Group 2: Lead Plaintiff Process - Investors in IAS have until March 31, 2025, to seek appointment as a lead plaintiff representative of the class or may choose to remain absent [3]. - A lead plaintiff acts on behalf of all class members and is typically the investor or group of investors with the largest financial interest [3]. - The lead plaintiff selects counsel to represent the class, and participation in any recovery is not affected by the decision to serve as a lead plaintiff [3]. Group 3: Law Firm Information - Kessler Topaz Meltzer & Check, LLP is handling the class action and encourages IAS investors who have suffered significant losses to contact them for more information [4]. - The firm has a global reputation for excellence in prosecuting class actions and has recovered billions for victims of corporate misconduct [4].

Core Viewpoint - A class action securities lawsuit has been filed against Integral Ad Science Holding Corp. for alleged securities fraud affecting investors between March 2, 2023, and February 27, 2024 [1][2]. Group 1: Allegations and Impact - The lawsuit claims that Integral Ad Science made false statements regarding its pricing strategy, indicating that the company faced increased competitive pricing pressures, leading to price cuts due to weakening demand and slowing revenue growth [2]. - It is alleged that the company's pricing function was no longer favorable, and it could not sustain or increase prices, which became a critical differentiator in closing major renewals and new deals [2]. - The complaint asserts that the risks of increased pricing pressure from competition had materialized, rendering the company's public statements misleading [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until March 31, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating no financial obligation to participate in the lawsuit [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Core Viewpoint - Rosen Law Firm is reminding purchasers of Integral Ad Science Holding Corp. common stock of the upcoming lead plaintiff deadline for a class action lawsuit, indicating potential compensation for affected investors [1][2]. Group 1: Class Action Details - The class action lawsuit pertains to investors who purchased IAS common stock between March 2, 2023, and February 27, 2024, with a lead plaintiff deadline set for March 31, 2025 [1][2]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in this area [3]. - The firm has achieved significant settlements, including over $438 million for investors in 2019 and has been consistently ranked among the top firms for securities class action settlements [3]. Group 3: Case Allegations - The lawsuit alleges that IAS failed to disclose critical information regarding competitive pricing pressures, which led to a decline in revenue growth and necessitated price cuts [4]. - Specific claims include that IAS's pricing function was no longer favorable, and competition had resulted in increased pricing pressure, making previous public statements materially false and misleading [4].

Core Viewpoint - A securities class action lawsuit has been filed against Integral Ad Science Holding Corp. (IAS) for allegedly making false and misleading statements regarding its business operations and financial health during the class period from March 2, 2023, to February 27, 2024 [1]. Group 1: Allegations Against IAS - The lawsuit claims that IAS faced increased competitive pricing pressures, leading to price cuts due to weakening demand and slowing revenue growth [3]. - It is alleged that IAS's pricing function was no longer favorable, and the company could not sustain or increase its pricing [3]. - The complaint states that pricing had become a key differentiator for IAS, and favorable pricing was necessary to secure major renewals and new deals [3]. - The risk of increased pricing pressure from competition was realized, contradicting IAS's previous statements about its business prospects [3]. - Overall, the defendants' statements regarding the company's operations and future were deemed materially false and misleading [3]. Group 2: Lead Plaintiff Process - Investors in IAS have until March 31, 2025, to seek appointment as a lead plaintiff representative for the class through Kessler Topaz Meltzer & Check, LLP or other counsel [4]. - A lead plaintiff acts on behalf of all class members and is typically the investor or group of investors with the largest financial interest [4]. - The decision to serve as a lead plaintiff does not affect an investor's ability to share in any recovery from the lawsuit [4].